admin

by Sarah Kwon This story also ran on NBC News. For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19
0 Comments
In early December, Dr. Katy Stephenson was watching TV with her family and scrolling through Twitter when she saw a tweet that made her shout. “I said ‘Oh, my God!’ ” she recalled. “Super loud. My kids jumped up. My husband looked over. He said, ‘What’s wrong, what’s wrong, is everything OK?’ I was like, ‘No, no, it’s
0 Comments
Oftentimes, I find myself standing in front of the pantry looking for something small and healthy that I could take on the go. As someone living with type 1 diabetes, “grabbing something” takes more thought than you’d like, as you want this snack to be kind to your blood sugars…and your waistline. Since NRG bites
0 Comments
Satjit Bhusri, MD, is worried about heart health, his own, and yours. A long-time New York City cardiologist, he is now treating the aftereffects of Covid-19. “What’s unusual about COVID…is that it is extremely inflammatory. That means the body attacks [the virus], and [the immune system] kind of goes overboard,” he said. What is unnerving
0 Comments
22 February 2021 — AstraZeneca today announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer. This decision was made in consultation with the Food and Drug Administration (FDA). In May 2017, Imfinzi was granted accelerated approval in the US based on promising
0 Comments
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45 CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) —  Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Amondys
0 Comments
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta. Tami Chappell | Reuters A new CDC study found that some elderly who apparently recovered from the coronavirus later came down with a second, even worse infection — indicating that asymptomatic or mild cases may not provide a lot of
0 Comments
Ahead of Rare Disease Day (28 February), four leading children’s research institutions on three continents are joining forces to decipher pediatric illnesses, including rare diseases, and find better treatments. The four pediatric hospitals — Boston Children’s Hospital; UCL Great Ormond Street Institute for Child Health and Great Ormond Street Hospital (London); the Murdoch Children’s Research
0 Comments
Multisystem inflammatory syndrome in children (MIS-C) has seen a surge in cases trailing the winter wave of COVID-19 in adults, but the treatment and recognition of it are better than in the earlier waves, clinicians and researchers say. Over the last 30 days, there have been around 11 cases of this SARS-CoV-2 infection-linked syndrome at
0 Comments
Formal exams have been cancelled in favour of teacher-led assessments The coronavirus pandemic has impacted the education system in a big way, with various attempts made by the government to soften the blow to those taking exams. Last year, the approach was described by many as chaotic as a controversial algorithm was initially used to
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two research teams have identified a new coronavirus variant in New York City and across the Northeast that could evade natural immune responses and some monoclonal antibody treatments, according to CNN. The variant, called B.1.526, has appeared in diverse neighborhoods in
0 Comments
In December, the Supreme Court reversed a lower court ruling that had allowed abortion medications to be sent by mail. Since then, women looking to terminate a pregnancy with the combination medications packet containing mifepristone and misoprostol now must go, in person, to a medical provider. But this in-person requirement is not necessary in many
0 Comments
maralixibat Treatment for Cholestatic Pruritus in Patients with Alagille Syndrome Mirum Pharmaceuticals Announces Completion of Rolling NDA Submission for Maralixibat in Alagille Syndrome FOSTER CITY, Calif.–(BUSINESS WIRE)–Feb. 1, 2021– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced it has completed submission of its rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for maralixibat for the
0 Comments
Dr. Peter Hotez told CNBC’s “The News with Shepard Smith” that people in the U.S. should not become complacent because of dropping Covid cases, especially amid new reports of a new variant, B.1.526, spreading in New York. “We’re all high fiving ourselves because the numbers are going down, and I am saying that we are
0 Comments
Adding an immunomodulator to standard R-CHOP therapy failed to improve progression-free survival in high-risk diffuse large B-cell lymphoma (DLBCL), an international randomized trial showed. Although median progression-free survival (PFS) had yet to be reached, the trial did not meet the prespecified 37.5% reduction in hazard ratio (HR) with R-CHOP plus lenalidomide (Revlimid, R2-CHOP). Instead, adding
0 Comments
The path to becoming a doctor is challenging. First college as a pre-med, then medical school, and finally residency. Which part is the most challenging? In this video we’ll go over each stage. Vlog channel: https://youtube.com/lifeofasurgeon Pre-med Roadmap to Med School Acceptance: https://medschoolinsiders.com/all-courses/ College vs Medical School: https://youtu.be/PgHotL0MOVM Med School vs Residency: https://youtu.be/3mFF8It-oG8 My Struggles
0 Comments